Catalytic Wealth RIA LLC bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 9,276 shares of the company’s stock, valued at approximately $1,438,000. Several other institutional investors and hedge funds also recently made […]
Legacy Advisors LLC cut its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 8.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 19,051 shares of the company’s stock after selling 1,753 shares during the quarter. Legacy Advisors LLC’s holdings in AbbVie were worth $2,952,000 as of its most recent SEC filing. […]
Weiss Asset Management LP bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,110 shares of the company’s stock, valued at approximately $792,000. A number of other large investors […]
3Chopt Investment Partners LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 9,301 shares of the company’s stock, valued at approximately $1,441,000. Several other large investors have also […]
CAP Partners LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 2,238 shares of the company’s stock, valued at approximately $347,000. A number of other institutional investors also recently modified their holdings of the stock. DiNuzzo Private Wealth Inc. acquired a […]